Porcine Versus Pericardial Pulmonary Valve Replacement in Adults With Prior Congenital Cardiac Surgery: Midterm Outcomes

Abstract

Background:

Postcongenital heart surgery pulmonary regurgitation requires subsequent pulmonary valve replacement. We sought to compare the outcomes of pulmonary valve replacement after using bioprosthetic valves, porcine versus pericardial bioprosthesis.

Method:

Retrospective single-center study of consecutive pulmonary valve replacement in patients with pulmonary regurgitation following initial congenital cardiac surgery. From 2004 to 2016, 82 adult patients (53 males, 29 females) underwent pulmonary valve replacement at a mean age of 28.7 ± 8 years (range 18-52 years) with a mean time to pulmonary valve replacement of 24 ± 7 years (range 13-43 years). Porcine bioprosthetic valves (group 1, n = 32) and pericardial valves (group 2, n = 50) were used. Cardiac magnetic resonance imaging was performed (n = 54) at a mean of 18 ± 13 months before and 24 ± 21 months after pulmonary valve replacement.

Results:

No significant difference was seen between the groups except that the mean follow-up was longer for group 1 (5.02 ± 2.06 vs 4.08 ± 3.21 years). In-hospital mortality was 1.1%. Follow-up completeness was 100% with no late death. Mean right ventricular end-systolic and end-diastolic volumes reduced significantly in both the groups (P < .001), whereas right ventricular ejection fraction remained unchanged (group 1, P = .129; group 2, P = .675) . Only the left ventricular end-diastolic volume increased in both the groups, but the increase was significant for group 2 only (group 1, P = .070; group 2, P = .015), whereas the left ventricular end-systolic and ejection fraction remained unchanged in both the groups. There was no reoperation for pulmonary valve replacement. Freedom from intervention was 93.8% (group 1) and 100% (group 2) at eight years after pulmonary valve replacement (P = .407).

Conclusion:

Midterm outcomes of pulmonary valve replacement in our adult cohort were satisfactory. Both types of bioprosthetic valves performed comparably for eight years and were a good option in adults.

Keywords

pulmonary valve adult congenital heart disease heart valves bioprosthesis

Get full access to this article

View all access options for this article.

References

Apitz

Webb

Redington

. Tetralogy of Fallot. Lancet. 2009;374(9699):1462–1471. doi:10.1016/s0140-6736(09)60657-7.

Indications for pulmonary valve replacement in repaired tetralogy of Fallot: the quest continues. Circulation. 2013;128(17):1855–1857. doi:10.1161/circulationaha.113.005878.

Chaturvedi

Redington

. Pulmonary regurgitation in congenital heart disease. Heart. 2007;93(7):880–889. doi:10.1136/hrt.2005.075234.

Rosti

Murzi

Colli

. Mechanical valves in the pulmonary position: a reappraisal. J Thorac Cardiovasc Surg. 1998;115(5):1074–1079. doi:10.1016/s0022-5223(98)70407-6.

Quintessenza

Jacobs

Morell

Giroud

Boucek

. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2005;79(3):924–931. doi:10.1016/j.athoracsur.2004.05.045.

Oosterhof

Meijboom

Vliegen

. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J. 2006;27(12):1478–1484. doi:10.1093/eurheartj/ehl033.

Fiore

Rodefeld

Turrentine

. Pulmonary valve replacement: a comparison of three biological valves. Ann Thorac Surg. 2008;85(5):1712–1718; discussion 1718. doi:10.1016/j.athoracsur.2008.02.001.

Abbas

Hoschtitzky

. Is there a role for mechanical valve prostheses in pulmonary valve replacement late after tetralogy of Fallot repair? Interact Cardiovasc Thorac Surg. 2014;18(5):661–666. doi:10.1093/icvts/ivt541.

Horer

Vogt

Stierle

. A comparative study of mechanical and homograft prostheses in the pulmonary position. Ann Thorac Surg. 2009;88(5):1534–1539. doi:10.1016/j.athoracsur.2009.07.022.

10.

Fukada

Morishita

Komatsu

Abe

. Influence of pulmonic position on durability of bioprosthetic heart valves. Ann Thorac Surg. 1997;64(6):1678–1680; discussion 1680-1671.

11.

Kwak

Lee

Kim

. Mid-term results of the Hancock II valve and carpentier-edward perimount valve in the pulmonary portion in congenital heart disease. Heart Lung Circ. 2010;19(4):243–246. doi:10.1016/j.hlc.2009.10.009.

12.

Zubairi

Malik

Jaquiss

Imamura

Gossett

Morrow

. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg. 2011;91(2):561–565. doi:10.1016/j.athoracsur.2010.07.111.

13.

Lee

Park

Lee

. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142(2):351–358. doi:10.1016/j.jtcvs.2010.12.020.

14.

Chen

Smith

Jaggers

Lodge

. Bioprosthetic pulmonary valve replacement: contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg. 2013;146(6):1461–1466. doi:10.1016/j.jtcvs.2012.09.081.

15.

Tretter

Friedberg

Wald

McElhinney

. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol. 2016;221:916–925. doi:10.1016/j.ijcard.2016.07.120.

16.

Graham

Jr. Cordell

Atwood

. Right ventricular volume characteristics before and after palliative and reparative operation in tetralogy of Fallot. Circulation. 1976;54(3):417–423.

17.

Discigil

Dearani

Puga

. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2001;121(2):344–351. doi:10.1067/mtc.2001.111209.

18.

Piazza

Chessa

Giamberti

. Timing of pulmonary valve replacement after tetralogy of Fallot repair. Expert Rev Cardiovasc Ther. 2012;10(7):917–923. doi:10.1586/erc.12.67.

19.

Dos

Munoz-Guijosa

Mendez

. Long term outcome of mechanical valve prosthesis in the pulmonary position. Int J Cardiol. 2011;150(2):173–176. doi:10.1016/j.ijcard.2010.04.004.

20.

Emani

. Options for prosthetic pulmonary valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2012;15(1):34–37. doi:10.1053/j.pcsu.2012.01.015.

21.

Cheung

Wong

Cheung

. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol. 2010;106(4):552–557. doi:10.1016/j.amjcard.2010.03.065.

22.

Ferraz Cavalcanti

Santos

. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62(23):2227–2243. doi:10.1016/j.jacc.2013.04.107.

23.

Frigiola

Tsang

Nordmeyer

. Current approaches to pulmonary regurgitation. Eur J Cardiothorac Surg. 2008;34(3):576–580; discussion 581-572. doi:10.1016/j.ejcts.2008.04.046.

24.

Oosterhof

van Straten

Vliegen

. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116(5):545–551. doi:10.1161/circulationaha.106.659664.

25.

Lindsey

Parks

Kogon

Sallee

III Mahle

. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg. 2010;89(1):147–151. doi:10.1016/j.athoracsur.2009.07.039.

26.

van Huysduynen

van Straten

Swenne

. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J. 2005;26(9):928–932. doi:10.1093/eurheartj/ehi140.

27.

Jang

Kim

Choi

Lim

Kim

Lee

. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg. 2012;42(1):e1–e8. doi:10.1093/ejcts/ezs219.